PPT-Testosterone, anastrozole and venous thrombosis

Rebecca Glaser MD 22052017 Background Testosterone anastrozole and venous thrombosis FDA warning 06192014 The US Food and Drug Administration FDA is requiring manufacturers to include a general warning in the drug labeling of all approved testosterone products about the risk of blood clots in the veins. Reaching New Heights in Understanding CVC Complications . Michael Brazunas, RN, BSN, VA-BC. Disclosures. AngioDynamics, Inc.. Association for Vascular Access – Director-at-Large. Objective. Identify 3 central venous catheter (CVC) complications. Rounds. Eddie Apenbrinck M.D. .. University of Louisville School of Medicine. Department of Ophthalmology & Visual Sciences. 5/1/2015. Subjective. CC: blurry vision and headache. HPI:47 year old white male admitted to the VA hospital for syncope after climbing a flight of stairs 2 days prior to admission. Consulted for blurry vision associated with headache.. Causes. Risk Factors. Symptoms. Importance. Treatments. Content. Introduction. Aims. Methods. Results. Conclusions. Collecting . Articles. Research . Question. Query. Inclusion / Exclusion criteria. Data to extract from the . Thrombi . are solid masses or plugs formed in the. circulation from blood constituents. Platelets . and fibrin . form the basic . structure. . . Their . clinical significance. results from . ischaemia. Reaching New Heights in Understanding CVC Complications . Michael Brazunas, RN, BSN, VA-BC. Disclosures. AngioDynamics, Inc.. Association for Vascular Access – Director-at-Large. Objective. Identify 3 central venous catheter (CVC) complications. circulation from blood constituents. Platelets . and fibrin . form the basic . structure. . . Their . clinical significance. results from . ischaemia. from local vascular. Obstruction. . or distant . Reaching New Heights in Understanding CVC Complications . Michael Brazunas, RN, BSN, VA-BC. Disclosures. AngioDynamics, Inc.. Association for Vascular Access – Director-at-Large. Objective. Identify 3 central venous catheter (CVC) complications. Rudolph Virchow, 1821-1902. Vessel wall injury. Stasis of blood. Hypercoagulability of blood. Arterial Thrombosis - 1. Interruption of blood flow causes . ischemic necrosis of involved . organ/limb. Vessel wall injury (. Overall annual incidence of CVST of 0.2-1.3 per 100,000 people.. 2. CVST prevalence of 29.2% among 140 cases with a skull fracture that crossed a cerebral venous sinus.. 2, 11. Higher incidence among females and neonates.. Assistant lecturer :. Noor Wafaa Hashim. Thrombosis is the development of a ‘thrombus’ consisting of platelets, fibrin, red cells and white cells in the arterial or venous circulation. If part of this thrombus in the venous circulation breaks off and enters the right heart, it may be lodged in the pulmonary arterial circulation, causing . M.D. (. Hom. ). Prof.. & . HoD. Department of Pathology. Thrombosis. Thrombosis . is the formation of a blood clot within the vascular system during life.. . The blood clot is adherent to the vessel wall. karim. Roosevelt University . Definition/Signs and Symptoms. Deep vein thrombosis (DVT) – blood clot occurring in a deep vein. Classified as distal or proximal. Pulmonary embolism (PE) – blood clot occurring in artery of the lung. Prothrombotic. State . Ayman Mahmoud Alboudi. MD, . MSc. Rashid Hospital , Dubai, UAE. CVT is a rare disorder with incidence rate is around 1/100000. [1]. We are having about 6 cases per year in our hospital (Rashid hospital in . Dr.. . Siddharth. . Epidemiology and burden of the disease. The annual incidence of first episode of symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population[1]. overall incidence of venous thromboembolism (VTE) around 25% higher with the addition of pulmonary embolism (PE) events.[2].